2m 2m 2m 2m 2m 2m 2m
Yubo Intl Bio-A (YBGJ)
OTC
$0.008-$0.002 (-16.00%)
Price as of Apr 28, 2026- $1.4MMarket Cap
- -88.28%1-Year Change
- Medical Instruments & SuppliesIndustry
Yubo Intl Bio-A (YBGJ)
$0.008-$0.002 (-16.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 12,353 +255.99% | 3,470 -99.43% | 604,676 +479.84% | 104,283 +24,322.25% | |
Cost of Revenue | 4,188 +409.49% | 822 -99.56% | 185,491 +259.26% | 51,631 -87.82% | |
Gross Profit | 8,165 +208.35% | 2,648 -99.37% | 419,185 +696.14% | 52,652 -93.58% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 177,773 -3.01% | 183,298 -3.53% | 190,012 +590.02% | 27,537 +28.67% | |
Total Operating Expenses | 1.2M -32.54% | 1.8M +9.83% | 1.6M +28.30% | 1.3M -47.00% | |
Operating Profit | -1.2M -32.90% | -1.8M +48.15% | -1.2M -0.87% | -1.2M -21.88% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -243 N/A | N/A N/A | -377 N/A | N/A N/A | |
Interest Income and Expense and Net | -243 N/A | 0 +100.00% | -377 N/A | 0 N/A | |
Total Nonoperating Income and Expense | -243 -99.89% | -211,873 +56,099.73% | -377 -264.63% | 229 -46.37% | |
Income before Taxes | -1.2M -40.06% | -2.0M +65.83% | -1.2M -0.82% | -1.2M -21.88% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.6M -17.81% | -2.0M +65.83% | -1.2M -0.82% | -1.2M -21.88% | |
Net Income from Continuing Operations Applicable to Common | -1.1M -39.21% | -1.8M +48.55% | -1.2M -0.82% | -1.2M -21.88% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.01 -50.00% | -0.02 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 139.6M +16.54% | 119.8M 0.00% | 119.8M +0.93% | 118.7M +0.50% | |
Diluted Weighted Average Shares | 139.6M +16.54% | 119.8M 0.00% | 119.8M +0.93% | 118.7M +0.50% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8,062 +14.93% | 7,015 +10.32% | 6,359 -65.10% | 18,220 -33.79% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 8,062 +14.93% | 7,015 +10.32% | 6,359 -65.10% | 18,220 -33.79% | |
Total Current Assets | 667,512 -2.23% | 682,751 -5.86% | 725,235 -3.30% | 750,012 -29.13% | |
Accumulated Depreciation | 184,476 +750.71% | 21,685 -88.37% | 186,417 +385.03% | 38,434 +67.68% | |
Property and Plant and Equipment and Net | 43,030 -79.10% | 205,911 -45.12% | 375,209 -39.15% | 616,652 -4.23% | |
Total Long-Term Assets | 43,030 -79.10% | 205,911 -45.12% | 375,209 -39.15% | 616,652 -4.23% | |
Total Assets | 847,094 -44.81% | 1.5M -7.94% | 1.7M -29.01% | 2.3M -48.80% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 1.1M +109.28% | |
Total Current Liabilities | 2.8M -40.88% | 4.7M +39.06% | 3.4M +34.55% | 2.5M -9.55% | |
Total Long-Term Debt | 99,229 0.00% | 99,229 0.00% | 99,229 0.00% | 99,229 N/A | |
Total Long-Term Liabilities | 0 -100.00% | 110,773 -4.12% | 115,527 -70.41% | 390,445 -79.75% | |
Total Liabilities | 2.8M -42.24% | 4.8M +37.64% | 3.5M +20.49% | 2.9M -38.24% | |
Retained Earnings | -7.7M +16.20% | -6.7M +36.34% | -4.9M +32.38% | -3.7M +48.48% | |
Total Stockholders Equity | -2.0M -42.92% | -3.4M +85.74% | -1.8M +226.10% | -565,373 +330.93% | |
Total Shares Outstanding | 119.8M 0.00% | 119.8M -0.004% | 119.8M +0.004% | 119.8M +1.39% | |
Cash Flow | |||||
Cash from Operating Activities | -842,802 -37.00% | -1.3M +81.03% | -738,971 -1,183.01% | 68,233 +106.68% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash from Investing Activities | 0 -100.00% | 118,431 N/A | 0 +100.00% | -39,772 -92.96% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 849,545 -39.63% | 1.4M +88.71% | 745,659 N/A | 0 -100.00% | |
Financials Ratio | |||||
Gross Margin | 66.10% -13.38% | 76.31% +10.08% | 69.32% +37.30% | 50.49% +100.05% | |
Operating Margin | -9,614.64% -81.15% | -51,006.31% +25,715.80% | -197.58% -82.90% | -1,155.72% -99.68% | |
Return on Assets | -136.77% +10.50% | -123.78% +107.97% | -59.52% +71.29% | -34.75% -48.33% | |
Return on Equity | 60.56% -19.50% | 75.24% -24.17% | 99.22% -71.32% | 345.98% -84.45% | |
Revenue Growth | 255.99% +357.47% | -99.43% -120.72% | 479.84% -98.03% | 24,322.25% N/A | |
Current Ratio | 0.24 +65.35% | 0.14 -32.30% | 0.21 -28.13% | 0.30 -21.65% | |
Cash Ratio | 0.003 +93.33% | 0.002 -21.05% | 0.002 -73.61% | 0.007 -27.27% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | -2.15 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.52 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow